Position in REGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$15,048,514
-$1,201,650 QoQ
Shares Held
24,134
+14.7% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#244
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IFM Investors Pty Ltd holds $76,274,918 across 7 Biotechnology names. REGN ranks #2 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
57,713 | $28,667,778 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
24,134 | $15,048,514 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,661 | $8,928,850 | |
| 4 | RPRX |
Royalty Pharma plc
|
124,013 | $6,953,408 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
35,035 | $6,561,354 | |
| 6 | INSM |
INSMED Inc
|
53,953 | $5,752,468 | |
| 7 | INCY |
Incyte Corp
|
38,484 | $4,362,546 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,048,514 | 24,134 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $16,250,164 | 21,032 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $16,007,040 | 20,738 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,618,185 | 20,663 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $11,180,925 | 21,297 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $13,476,119 | 21,248 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $15,208,245 | 21,350 | Shares | Sole | 2025-04-29 | |
| 2024-09-30 | $24,478,123 | 23,285 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $24,444,855 | 23,258 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $21,721,474 | 22,568 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $19,938,939 | 22,702 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $18,730,569 | 22,760 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $15,018,204 | 20,901 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $16,315,079 | 19,856 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $13,989,691 | 19,390 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,012,065 | 18,889 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $10,943,589 | 18,513 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $12,158,793 | 17,409 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $8,683,400 | 13,750 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $8,361,166 | 13,816 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $7,736,337 | 13,851 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $5,461,455 | 11,543 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,840,762 | 10,020 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $4,635,538 | 8,281 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $4,458,473 | 7,149 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $4,030,833 | 8,255 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||